Evidence map›Paper›PMID 39378872›Full record

ArticleThe American journal of tropical medicine and hygiene2025

Operational Research to Support Rapid Evidence-Based Responses to Outbreaks: Learnings from COVID-19.

Anne Hoppe, Pallavi Dani, Grace Mwangoka, Stephen Vreden, Guillaume Breton, Jerome Ateudjieu, Joaniter I Nankabirwa, Júlia Sambo, Rose Masaba, Tatenda Maparo and 13 more

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Anne HoppeFIND, Geneva, Switzerland.
Pallavi DaniFIND, Geneva, Switzerland.
Grace MwangokaBiomedical Research and Clinical Trials, Ifakara Health Institute, Bagamoyo, Tanzania.
Stephen VredenFoundation for the Advancement of Scientific Research, Paramaribo, Suriname.
Guillaume BretonTechnical Department, Solthis, Paris, France.
Jerome AteudjieuDepartment of Health Research and Intervention, M. A. SANTE, Yaoundé, Cameroon.
Joaniter I NankabirwaResearch Department, Infectious Diseases Research Collaboration, Kampala, Uganda.
Júlia SamboHealth Research Management & Coordination, Instituto Nacional de Saude, Maputo, Mozambique.
Rose MasabaResearch, Elizabeth Glaser Pediatric AIDS Foundation, Nairobi, Kenya.
Tatenda MaparoAccess Program, Clinton Health Access Initiative, Harare, Zimbabwe.
Goodman SibekoPsychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
Richard NjouomDepartment of Virology, Centre Pasteur of Cameroon, Yaoundé, Cameroon.
Boris TchoungaResearch, Elizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon.
Isaac SsewanyanaLaboratory Services, Central Public Health Laboratories, Kampala, Uganda.
Chancy ChavulaDiagnostics, Clinton Health Access Initiative, Lilongwe, Malawi.
Lindiwe NchimunyaDiagnostics, Clinton Health Access Initiative, Lusaka, Zambia.
Tatiana DjikeussiResearch, Elizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon.
Sam AccellamFIND, Geneva, Switzerland.
Hedley CairoMalaria Program, Ministry of Health Suriname, Paramaribo, Suriname.
David WalcottDepartment of Microbiology, University Hospital Of The West Indies, Kingston, Jamaica.
Aamir J KhanInfectious Diseases, IRD Global, Singapore, Singapore.
Shaukat KhanFIND, Geneva, Switzerland.
Daniel G BauschFIND, Geneva, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the COVID-19 pandemic, the need for making testing readily available was recognized as an important factor for individuals to help make informed decisions, including to isolate or seek care, and for policymakers to control transmission. Toward this end, FIND and the Access to COVID-19 Tools Accelerator funded 16 rapid operational research studies and one implementation project in Africa, the Caribbean, and Asia evaluating the utility, acceptability, and feasibility of different community-based SARS-CoV-2 testing approaches. Here, we discuss common factors and challenges encountered during study implementation. We note six key factors essential for success: 1) collaboration and partnerships; 2) buy-in of local stakeholders, including communities; 3) access to affordable supplies; 4) flexible financing; 5) effective approval systems; and 6) a skilled and motivated workforce. We also note various challenges that must be addressed to fully capitalize on these success factors. In particular, ethics committees are often not well equipped to assess operational research during outbreaks. Outbreaks, especially of novel pathogens, are unpredictable, and transmission dynamics are even more likely to change if the pathogen is prone to frequent mutations, such as SARS-CoV-2. Research that aims to evaluate strategies for curbing transmission must hence be easily and swiftly adaptable. This requires flexibility from researchers, funders, staff conducting the studies, and ethics and other approval committees. International guidelines for evaluating operational research protocols in outbreaks are needed to provide timely evidence to enable informed decisions by individuals, communities, and policymakers, thereby reducing both the human and the economic impact of outbreaks.

Indexed as

COVID-19Disease OutbreaksAfricaCOVID-19 TestingHumansPandemicsSARS-CoV-2

Identifiers

PMID39378872
PMCPMC11965719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.